Home

Toronto Dominion Bank reported a 4.9% stake in Stoke Therapeutics STOK · 3,173,258 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.9%
Last report
5.4% · filed 26/05/15
Shares held
3,173,258 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/06/30
Filed
26/08/12

4.9% stake · below 5%

Stake
4.9%
Last report
5.4%
Since last report
−0.5pp

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Toronto Dominion Bank's other 5% stake reports

  • Toronto Dominion Bank

    5% stakeUroGen Pharma

    6.7% stake

    Filed 08/12

  • 9% stake

    Filed 08/12

  • Toronto Dominion Bank

    5% stakeUroGen Pharma

    5.4% stake

    Filed 05/15

  • Toronto Dominion Bank

    5% stakePTC Therapeutics

    3.7% stake

    Filed 05/15

  • Toronto Dominion Bank

    5% stakeImmatics

    5.5% stake

    Filed 05/15